Ran Meropenem 500/ Ran Meropenem 1 G 500 mg & 1 g Injection.
PDF Leaflet Revision Date: 13 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible bacteria.
Dosage (summary)
500 mg to 1 g IV every 8 hours; adjust for renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established in pregnancy; avoid in breastfeeding.
Key Drug Interactions
- Probenecid
- Valproic acid
Contraindications
- Hypersensitivity to meropenem
- History of hypersensitivity to beta-lactams
Common side effects
- Nausea
- Diarrhoea
- Headache
- Rash
Counselling Points
- Report any allergic reactions
- Monitor for gastrointestinal symptoms
- Avoid in pregnancy and breastfeeding
Serious warnings
- Serious hypersensitivity reactions
- Seizures
- Antibiotic-associated colitis
Important Disclaimer
The Ran Meropenem 500/ Ran Meropenem 1 G 500 mg & 1 g Injection. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
